Active Ingredient(s): Tolcapone
FDA Approved: * January 29, 1998
Pharm Company: * VALEANT
Category: Parkinsons

Tolcapone, sold under the brand name Tasmar, is a medication used to treat Parkinson's disease (PD). It is a selective, potent and reversible nitrocatechol-type inhibitor of the enzyme catechol-O-methyltransferase (COMT).[1] It has demonstrated significant liver toxicity, which has led to suspension of marketing authorisations in a number of countries. In comparison with entacapone, another nitrocatechol COMT inhibitor, tolcapone has a longer half life (2.9 hours vs. 0.8 hour... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tasmar 100 mg Oral Tablet
NDC: 0187-0938
Valeant Pharmaceuticals North America LLC
Tasmar 200 mg Oral Tablet
NDC: 0187-0939
Valeant Pharmaceuticals North America LLC